Analysen von Keyur Parekh
| 25.03.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.03.19 | Bayer buy | Goldman Sachs Group Inc. | |
| 18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.03.19 | Merck Neutral | Goldman Sachs Group Inc. | |
| 05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.02.19 | Bayer buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.02.19 | Roche buy | Goldman Sachs Group Inc. | |
| 14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.02.19 | Merck Neutral | Goldman Sachs Group Inc. | |
| 12.02.19 | Bayer buy | Goldman Sachs Group Inc. | |
| 12.02.19 | Merck Neutral | Goldman Sachs Group Inc. | |
| 07.02.19 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 06.02.19 | GSK buy | Goldman Sachs Group Inc. | |
| 02.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.01.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.01.19 | GSK buy | Goldman Sachs Group Inc. | |
| 30.01.19 | Roche buy | Goldman Sachs Group Inc. | |
| 24.01.19 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.01.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.01.19 | Bayer buy | Goldman Sachs Group Inc. | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 19.12.18 | GSK buy | Goldman Sachs Group Inc. | |
| 14.12.18 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.12.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 11.12.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 03.12.18 | GSK buy | Goldman Sachs Group Inc. | |
| 29.11.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.11.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 19.11.18 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 16.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.11.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 13.11.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 08.11.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.11.18 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 02.11.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 01.11.18 | GSK buy | Goldman Sachs Group Inc. | |
| 31.10.18 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 31.10.18 | Merck Neutral | Goldman Sachs Group Inc. | |
| 31.10.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 26.10.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 23.10.18 | Bayer buy | Goldman Sachs Group Inc. | |
| 22.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 17.10.18 | Merck Neutral | Goldman Sachs Group Inc. | |